1. Management of malignant gastrointestinal stromal tumours;Joensuu;Lancet Oncol,2002
2. Gastrointestinal stromal tumors respond to tyrosine kinase-targeted therapy;Maki;Curr Treat Options Gastroenterol,2004
3. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002
4. STI 571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I study;van Oosterom;Proc Am Soc Clin Oncol,2001
5. DeMatteo RP, Owzar K, Antonescu CR, et al. Efficacy of adjuvant imatinib mesylate following complete resection of localized, primary gastrointestinal stromal tumor (GIST) at high risk of recurrence: The U.S. Intergroup phase II trial ACOSOG Z9000. ASCO 2008 Gastrointestinal Cancers Symposium 2008 (Abstract 8) 2008.